Withaferin A Ameliorated\nthe Bone Marrow Fat Content\nin Obese Male Mice by Favoring Osteogenesis in Bone Marrow Mesenchymal\nStem Cells and Preserving the Bone Mineral Density

Obesity and osteoporosis are two prevalent conditions\nthat are\nbecoming increasingly common worldwide, primarily due to aging populations,\nimbalanced energy intake, and sedentary lifestyles. Obesity, characterized\nby excessive fat accumulation, and osteoporosis, marked by reduced\nbone density and increased fracture risk, are often interconnected.\nHigh-fat diets (HFDs) can exacerbate both conditions by promoting\nbone marrow adiposity and bone loss. The effect of WFA on the osteogenesis\nand adipogenesis was studied on the C3H10T1/2 cell line and bone marrow\nmesenchymal stem cells (BM-MSCs) isolated from mice. We used oil red\nO and alkaline phosphatase (ALP) staining to observe adipogenesis\nand osteogenesis, respectively, in MSCs. Real-time PCR and Western\nblot analyses were used to study the molecular effects of WFA on MSCs.\nWe employed micro-CT to analyze the bone microarchitecture, bone mineral\ndensity (BMD), and abdominal fat mass in male mice. We have used osmium\ntetroxide (OsO<sub>4</sub>) staining to study the bone marrow fat.\nWFA induced the C3H10T1/2 cell line and BM-MSCs toward osteogenic\nlineage as evidenced by the higher ALP activity. WFA also downregulated\nthe lipid droplet formation and adipocyte specific genes in MSCs.\nIn the <i>in vivo</i> study, WFA also suppressed the bone\ncatabolic effects of the HFD and maintained the bone microarchitecture\nand BMD in WFA-treated animals. The bone marrow adipose tissue was\nreduced in the tibia of WFA-treated groups in comparison with only\nHFD-fed animals. Withaferin A was able to improve the bone microarchitecture\nand BMD by committing BM-MSCs toward osteogenic differentiation and\nreducing marrow adiposity. The findings of this study could provide\nvaluable insights into the therapeutic potential of Withaferin A for\ncombating bone marrow obesity and osteoporosis, particularly in the\ncontext of diet-induced metabolic disturbances.

Publication Details

Journal
Figshare
Published
2024-08-19
DOI
https://doi.org/10.1021/acsptsci.3c00356.s001
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Withaferin A Ameliorated\nthe Bone Marrow Fat Content\nin Obese Male Mice by Favoring Osteogenesis in Bone Marrow Mesenchymal\nStem Cells and Preserving the Bone Mineral Density

Figshare
Phytochemicals and Medicinal Plants
article

Withaferin A Ameliorated\nthe Bone Marrow Fat Content\nin Obese Male Mice by Favoring Osteogenesis in Bone Marrow Mesenchymal\nStem Cells and Preserving the Bone Mineral Density

article en

Abstract

Obesity and osteoporosis are two prevalent conditions\nthat are\nbecoming increasingly common worldwide, primarily due to aging populations,\nimbalanced energy intake, and sedentary lifestyles. Obesity, characterized\nby excessive fat accumulation, and osteoporosis, marked by reduced\nbone density and increased fracture risk, are often interconnected.\nHigh-fat diets (HFDs) can exacerbate both conditions by promoting\nbone marrow adiposity and bone loss. The effect of WFA on the osteogenesis\nand adipogenesis was studied on the C3H10T1/2 cell line and bone marrow\nmesenchymal stem cells (BM-MSCs) isolated from mice. We used oil red\nO and alkaline phosphatase (ALP) staining to observe adipogenesis\nand osteogenesis, respectively, in MSCs. Real-time PCR and Western\nblot analyses were used to study the molecular effects of WFA on MSCs.\nWe employed micro-CT to analyze the bone microarchitecture, bone mineral\ndensity (BMD), and abdominal fat mass in male mice. We have used osmium\ntetroxide (OsO<sub>4</sub>) staining to study the bone marrow fat.\nWFA induced the C3H10T1/2 cell line and BM-MSCs toward osteogenic\nlineage as evidenced by the higher ALP activity. WFA also downregulated\nthe lipid droplet formation and adipocyte specific genes in MSCs.\nIn the <i>in vivo</i> study, WFA also suppressed the bone\ncatabolic effects of the HFD and maintained the bone microarchitecture\nand BMD in WFA-treated animals. The bone marrow adipose tissue was\nreduced in the tibia of WFA-treated groups in comparison with only\nHFD-fed animals. Withaferin A was able to improve the bone microarchitecture\nand BMD by committing BM-MSCs toward osteogenic differentiation and\nreducing marrow adiposity. The findings of this study could provide\nvaluable insights into the therapeutic potential of Withaferin A for\ncombating bone marrow obesity and osteoporosis, particularly in the\ncontext of diet-induced metabolic disturbances.

Figshare
Openalex Percentile: Top 42%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.